Pear Bio
4 known investors
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
Investors · 4
In the news
- Pear Bio Secures $14 Million Series A Funding to Advance Predictive Cancer Treatmentsiliconvalleyjournals.com · 2023
- Pear Bio - Raised $14.2M Funding from 8 investors - Tracxntracxn.com · 2021
- Pear Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Pear Bio raised $14 million series A led by Octopus Ventures. | Nordic 9nordic9.com
- Pear Bio raises USD 14 million in Series A funding - SPEEDA Edgesp-edge.com